Erwin Syarifuddin

9PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Blood-Based vs. Tissue-Based mRNA Expression of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Methylenetetrahydrofolate Reductase: A Prospective Study to Predict the Neoadjuvant CAPEOX Response in Advanced Colorectal Cancer.

|Feb 09, 2026
Towards Precision Oncology: A Predictive Nomogram Incorporating DPD and MTHFR for CapeOX Neoadjuvant Chemotherapy in Colorectal Cancer.

Elvida Christy Imelda Tahiya, Ronald Erasio Lusikooy, Ilhamjaya Pattelongi

|Nov 28, 2025
Perioperative Thrombocytosis as a Predictor of Long-Term Survival in Colorectal Cancer Patients: A Retrospective Cohort Study.

Andi Tri Sutrisno, Erwin Syarifuddin, Samuel Sampetoding

|Oct 28, 2025
Advancing Non-Invasive Genomic Detection of p53 Tumor Suppressor Mutations in Fecal and Tumor Tissues of Colorectal Cancer Patients in Makassar.

Unggul Jatmiko, Warsinggih Warsinggih, A M Luthfi Parewangi

|Oct 28, 2025
Validation of Platelet-index based Score (PIBS) for Early Prediction of the Pathological Stage in Colorectal Cancer.

Adi Madethen, Ronald Erasio Lusikooy, Julianus Aboyaman Uwuratuw

|Aug 24, 2025
The Ideal Second-Line Treatment Options for Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine-Based First-Line Chemotherapy: A Result From Bayesian Network-Meta Analysis.

Erwin Syarifuddin, Citra Aryanti

Pageof 2

Frequent Collaborators

6 joint publications

Citra Aryanti

6 joint publications

Samuel Sampetoding

6 joint publications

Warsinggih Warsinggih

6 joint publications

Julianus Aboyaman Uwuratuw